Global Alliance for TB Drug Development   Report issue

Contributed to NME Foundation Phase 1 Phase 3
Founded: Cape Town South Africa (2000)

Organization Overview

First Clinical Trial
2006
NCT00144417
First Marketed Drug
2019
pretomanid
First NDA Approval
2019
pretomanid
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Global Alliance for TB Drug Development